Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.   5 March 2019
Big Pharma
An opinion on whether a supplementary protection certificate can be granted to an owner of a drug patent when the marketing authorisation is held by a third party is overdue, lawyers told LSIPR.   5 March 2019
Big Pharma
The UK Competition and Markets Authority has provisionally found that pharmaceutical companies Auden Mckenzie and Waymade engaged in anti-competitive behaviour relating to hydrocortisone tablets.   4 March 2019
Americas
The US International Trade Commission has begun an investigation into Daewoong Pharmaceuticals of South Korea and California-based Evolus, following a complaint from Allergan.   4 March 2019
Big Pharma
The patents division of the English High Court has found that a patent owned by Genentech is invalid and denied the biotechnology company’s application for a supplementary protection certificate.   1 March 2019
Americas
The US Federal Trade Commission concluded a ten-year pay-for-delay suit yesterday, with AbbVie agreeing not to enter certain settlements in patent cases that delay market entry of generic drugs.   1 March 2019
Medtech
The US International Trade Commission has begun an investigation into whether a Danish company’s dental and orthodontic scanners and software infringed an American company’s patents.   28 February 2019
Americas
Patterson Belknap Webb & Tyler has hired Barbara Mullin, a former lawyer at Akin Gump Strauss Hauer & Feld, as special counsel.   28 February 2019
Big Pharma
A US judge has ordered Boehringer Ingelheim to release its rollout plans for a biosimilar version of Humira (adalimumab), following a request from AbbVie.   28 February 2019
Big Pharma
General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.   28 February 2019